Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma

Author:

Toner Keri1ORCID,Allen Carl E.2,Jain Shweta3,Kahl Brad4,Leonard John5,Wasserstrom Heather6,Friedberg Jonathan W.7,Seibel Nita L.8,Kelly Kara9

Affiliation:

1. Center for Cancer and Blood Disorders Children's National Hospital Washington District of Columbia USA

2. Baylor College of Medicine Texas Children's Hospital Houston Texas USA

3. Clinical Development Seagen Inc. Bothell Washington USA

4. Department of Medicine Division of Oncology Washington University in St. Louis School of Medicine St. Louis Missouri USA

5. Weill Department of Medicine Division of Hematology and Medical Oncology Weill Cornell Medicine New York New York USA

6. Clinical Development Team Pediatrics Hematology and Cellular Therapy at Bristol Myers Squibb New York New York USA

7. Wilmot Cancer Institute University of Rochester Rochester New York USA

8. Division of Cancer Treatment and Diagnosis National Cancer Institute National Institutes of Health Bethesda Maryland USA

9. Roswell Park Comprehensive Cancer Center University at Buffalo Jacobs School of Medicine and Biomedical Sciences Buffalo New York USA

Abstract

AbstractLymphoma is one of the most common cancers in adolescents and young adults, but historically, this population has had lower clinical trial enrollment and improvements in overall survival as compared to other age populations. There are multiple challenges that are unique to this population that have affected drug development and clinical trial enrollment. Our panel of experts have identified barriers, and in this review, we discuss current methods to address these barriers as well as potential solutions moving forward.

Publisher

Wiley

Subject

General Earth and Planetary Sciences

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3